WINNEBAGO INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WINNEBAGO INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Aug 31, 2019 | $530.40M | Oct 23, 2019 |
| FY2019 | May 25, 2019 | $528.94M | Oct 23, 2019 |
| FY2019 | Feb 23, 2019 | $432.69M | Oct 23, 2019 |
| FY2019 | Nov 24, 2018 | $493.65M | Oct 23, 2019 |
| FY2019 | Aug 25, 2018 | $536.19M | Oct 23, 2019 |
| FY2019 | May 26, 2018 | $562.26M | Oct 23, 2019 |
| FY2019 | Feb 24, 2018 | $468.36M | Oct 23, 2019 |
| FY2019 | Nov 25, 2017 | $450.02M | Oct 23, 2019 |
| FY2018 | Aug 26, 2017 | $454.94M | Oct 18, 2018 |
| FY2018 | May 27, 2017 | $476.36M | Oct 18, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $2.80B | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $2.97B | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $3.49B | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $4.96B | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $3.63B | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | $737.81M | Oct 21, 2020 |
| FY2020 | May 30, 2020 | $402.46M | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | $626.81M | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | $588.46M | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | $530.40M | Oct 21, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 26, 2017 | $454.94M | Oct 20, 2017 |
| FY2017 | May 27, 2017 | $476.36M | Oct 20, 2017 |
| FY2017 | Feb 25, 2017 | $370.51M | Oct 20, 2017 |
| FY2017 | Nov 26, 2016 | $245.31M | Oct 20, 2017 |
| FY2017 | Aug 27, 2016 | $263.25M | Oct 20, 2017 |
| FY2017 | May 28, 2016 | $272.08M | Oct 20, 2017 |
| FY2017 | Feb 27, 2016 | $225.67M | Oct 20, 2017 |
| FY2017 | Nov 28, 2015 | $214.22M | Oct 20, 2017 |
| FY2016 | Aug 29, 2015 | $251.05M | Oct 18, 2016 |
| FY2016 | May 30, 2015 | $266.51M | Oct 18, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $365.10M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $433.50M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $586.10M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $929.30M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $650.40M | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | $122.51M | Oct 21, 2020 |
| FY2020 | May 30, 2020 | $32.02M | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | $79.78M | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | $78.61M | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | $83.19M | Oct 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $25.70M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $13.00M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $215.90M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $390.60M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $281.90M | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | $42.46M | Oct 21, 2020 |
| FY2020 | May 30, 2020 | ($12.35M) | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | $17.27M | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | $14.07M | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | $31.87M | Oct 21, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $57.20M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $100.20M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $300.70M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $583.50M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $407.40M | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | $68.40M | Oct 21, 2020 |
| FY2020 | May 30, 2020 | ($8.17M) | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | $29.64M | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | $23.89M | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | $44.77M | Oct 21, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Aug 27, 2016 | $4.00M | Oct 18, 2016 |
| FY2016 | Aug 29, 2015 | $3.90M | Oct 18, 2016 |
| FY2016 | Aug 30, 2014 | $4.30M | Oct 18, 2016 |
| FY2015 | Aug 31, 2013 | $3.80M | Oct 27, 2015 |
| FY2014 | Aug 25, 2012 | $3.40M | Oct 28, 2014 |
| FY2013 | Aug 27, 2011 | $3.20M | Oct 29, 2013 |
| FY2012 | Aug 28, 2010 | $3.20M | Oct 23, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $285.80M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $280.00M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $267.70M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $316.40M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $228.60M | Oct 18, 2023 |
| FY2022 | Aug 29, 2020 | $177.06M | Oct 19, 2022 |
| FY2021 | Aug 31, 2019 | $142.30M | Oct 20, 2021 |
| FY2020 | Aug 25, 2018 | $130.12M | Oct 21, 2020 |
| FY2019 | Aug 26, 2017 | $97.61M | Oct 23, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $128.90M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $143.90M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $294.50M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $400.60M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $237.30M | Oct 18, 2023 |
| FY2022 | Aug 29, 2020 | $270.43M | Oct 19, 2022 |
| FY2021 | Aug 31, 2019 | $133.75M | Oct 20, 2021 |
| FY2020 | Aug 25, 2018 | $83.35M | Oct 21, 2020 |
| FY2019 | Aug 26, 2017 | $97.13M | Oct 23, 2019 |
| FY2018 | Aug 27, 2016 | $52.75M | Oct 18, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $39.40M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $45.00M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $83.20M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $88.00M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $44.90M | Oct 18, 2023 |
| FY2022 | Aug 29, 2020 | $32.38M | Oct 19, 2022 |
| FY2021 | Aug 31, 2019 | $40.86M | Oct 20, 2021 |
| FY2020 | Aug 25, 2018 | $28.67M | Oct 21, 2020 |
| FY2019 | Aug 26, 2017 | $13.99M | Oct 23, 2019 |
| FY2018 | Aug 27, 2016 | $24.55M | Oct 18, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $2.15B | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $2.38B | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $2.43B | Oct 22, 2025 |
| FY2023 | Aug 27, 2022 | $2.42B | Oct 18, 2023 |
| FY2022 | Aug 28, 2021 | $2.06B | Oct 19, 2022 |
| FY2021 | Aug 29, 2020 | $1.71B | Oct 20, 2021 |
| FY2020 | Aug 31, 2019 | $1.10B | Oct 21, 2020 |
| FY2019 | Aug 25, 2018 | $1.05B | Oct 23, 2019 |
| FY2018 | Aug 26, 2017 | $902.51M | Oct 18, 2018 |
| FY2017 | Aug 27, 2016 | $390.72M | Oct 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $929.70M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $1.11B | Oct 22, 2025 |
| FY2024 | Aug 26, 2023 | $1.06B | Oct 23, 2024 |
| FY2023 | Aug 27, 2022 | $1.15B | Oct 18, 2023 |
| FY2022 | Aug 28, 2021 | $1.01B | Oct 19, 2022 |
| FY2021 | Aug 29, 2020 | $886.23M | Oct 20, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $1.22B | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $1.27B | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $1.37B | Oct 22, 2025 |
| FY2025 | Aug 27, 2022 | $1.26B | Oct 22, 2025 |
| FY2024 | Aug 28, 2021 | $1.06B | Oct 23, 2024 |
| FY2023 | Aug 29, 2020 | $827.50M | Oct 18, 2023 |
| FY2022 | Aug 31, 2019 | $632.21M | Oct 19, 2022 |
| FY2021 | Aug 25, 2018 | $534.45M | Oct 20, 2021 |
| FY2020 | Aug 26, 2017 | $441.67M | Oct 21, 2020 |
| FY2017 | Aug 27, 2016 | $268.36M | Oct 20, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $484.20M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $484.20M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $514.50M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $484.20M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $348.10M | Oct 18, 2023 |
| FY2022 | Aug 29, 2020 | $348.06M | Oct 19, 2022 |
| FY2021 | Aug 31, 2019 | $274.93M | Oct 20, 2021 |
| FY2021 | Aug 25, 2018 | $274.37M | Oct 20, 2021 |
| FY2020 | Aug 26, 2017 | $242.73M | Oct 21, 2020 |
| FY2019 | Aug 27, 2016 | $1.23M | Oct 23, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $1.71B | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $1.72B | Oct 22, 2025 |
| FY2024 | Aug 26, 2023 | $1.75B | Oct 23, 2024 |
| FY2023 | Aug 27, 2022 | $1.54B | Oct 18, 2023 |
| FY2022 | Aug 28, 2021 | $1.17B | Oct 19, 2022 |
| FY2021 | Aug 29, 2020 | $913.61M | Oct 20, 2021 |
| FY2020 | Aug 31, 2019 | $866.89M | Oct 21, 2020 |
| FY2019 | Aug 25, 2018 | $768.82M | Oct 23, 2019 |
| FY2018 | Aug 26, 2017 | $679.14M | Oct 18, 2018 |
| FY2017 | Aug 27, 2016 | $620.55M | Oct 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $174.00M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $330.90M | Oct 22, 2025 |
| FY2024 | Aug 26, 2023 | $309.90M | Oct 23, 2024 |
| FY2023 | Aug 27, 2022 | $282.20M | Oct 18, 2023 |
| FY2022 | Aug 28, 2021 | $434.56M | Oct 19, 2022 |
| FY2021 | Aug 29, 2020 | $292.58M | Oct 20, 2021 |
| FY2020 | Aug 31, 2019 | $37.43M | Oct 21, 2020 |
| FY2019 | Aug 25, 2018 | $2.34M | Oct 23, 2019 |
| FY2019 | Aug 26, 2017 | $35.95M | Oct 23, 2019 |
| FY2019 | Aug 27, 2016 | $85.58M | Oct 23, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $540.50M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $637.10M | Oct 22, 2025 |
| FY2024 | Aug 26, 2023 | $592.40M | Oct 23, 2024 |
| FY2023 | Aug 27, 2022 | $545.90M | Oct 18, 2023 |
| FY2022 | Aug 28, 2021 | $528.56M | Oct 19, 2022 |
| FY2021 | Aug 29, 2020 | $512.63M | Oct 20, 2021 |
| FY2020 | Aug 31, 2019 | $254.29M | Oct 21, 2020 |
| FY2019 | Aug 25, 2018 | $291.44M | Oct 23, 2019 |
| FY2018 | Aug 26, 2017 | $274.58M | Oct 18, 2018 |
| FY2017 | Aug 27, 2016 | $0 | Oct 20, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | 0 | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | 7 | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | 12 | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | 8 | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | 1 | Oct 21, 2020 |
| FY2020 | May 30, 2020 | 0 | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | 1 | Oct 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | 0 | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | 6 | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | 11 | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | 8 | Oct 18, 2023 |
| FY2020 | Aug 29, 2020 | 1 | Oct 21, 2020 |
| FY2020 | May 30, 2020 | 0 | Oct 21, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Oct 21, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Oct 21, 2020 |
| FY2020 | Aug 31, 2019 | 1 | Oct 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 28, 2021 | 51.78M | Oct 20, 2021 |
| FY2021 | Aug 29, 2020 | 51.78M | Oct 20, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $38.90M | Oct 22, 2025 |
| FY2025 | Aug 31, 2024 | $36.80M | Oct 22, 2025 |
| FY2025 | Aug 26, 2023 | $33.20M | Oct 22, 2025 |
| FY2024 | Aug 27, 2022 | $23.80M | Oct 23, 2024 |
| FY2023 | Aug 28, 2021 | $16.20M | Oct 18, 2023 |
| FY2022 | Aug 29, 2020 | $14.59M | Oct 19, 2022 |
| FY2021 | Aug 31, 2019 | $13.67M | Oct 20, 2021 |
| FY2020 | Aug 25, 2018 | $12.74M | Oct 21, 2020 |
| FY2019 | Aug 26, 2017 | $12.74M | Oct 23, 2019 |
| FY2018 | Aug 27, 2016 | $10.89M | Oct 18, 2018 |